Programming DNA Nanoassembly for Enhanced Photodynamic Therapy

Angew Chem Int Ed Engl. 2020 Jan 27;59(5):1897-1905. doi: 10.1002/anie.201912574. Epub 2019 Dec 9.

Abstract

Photodynamic therapy (PDT) has extraordinary promise for the treatment of many cancers. However, its clinical progress is impaired by the intrinsic hypoxic tumor microenvironment that limits PDT efficacy and the safety concern associated with biological specificity of photosensitizers or vehicles. Now it is demonstrated that rationally designed DNA nanosponges can load and delivery photosensitizer effectively, target tumor precisely, and relieve hypoxia-associated resistance remarkably to enhance the efficacy of PDT. Specifically, the approach exhibits a facile assembly process, provides programmable and versatile nanocarriers, and enables robust in vitro and in vivo anti-cancer efficacy with excellent biosafety. These findings represent a practical and safe approach by designer DNA nanoassemblies to combat cancer effectively and suggest a powerful strategy for broad biomedical application of PDT.

Keywords: DNA nanotechnology; cancer therapy; nucleic acids; photodynamic therapy; self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA / genetics*
  • Humans
  • Photochemotherapy / methods*

Substances

  • DNA